483
Haematologic Technologies, LLC dba ProlytixFDA 483 - Haematologic Technologies, LLC dba Prolytix - May 11, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Haemtech Biopharma Services, a control testing laboratory in Essex Junction, VT, identified a significant deficiency in their quality control strategies. The firm failed to ensure that all original laboratory records, including electronic data, were subjected to a documented second-person review for accuracy. This observation highlights a concern regarding data integrity and proper reporting of test results for client drug samples.
Open in Dashboard
ID · aea0025e-2196-4a23-bc0c-9adb9107d7cf